News

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Older Americans worried about cognitive decline can stay sharper for longer by exercising both their bodies and their brains ...
The biggest buzz around GLP-1 drugs these days has nothing to do with weight loss. And that might lead to some problems for ...
Compared with other antidiabetic drugs, semaglutide is associated with a lower risk for Alzheimer disease-related dementia in patients with type 2 diabetes.
GLP-1 drugs may reduce asthma symptoms in obese adults, offering a steroid-free alternative to treatment. The study includes ...
Mounjaro kick-started my weight loss, but true success came from hard work, persistence and changing bad habits ...
Neuroscientist Sabina Brennan encourages caregivers to live in the moment and notice the happy experiences they share with ...
Key messages • It is known that older people who take more medicines with an anticholinergic effect may be at greater risk of cognitive decline. • There is a lack of high-quality evidence to show ...
Background Dementia has become a public health burden worldwide. Caring for people with dementia is highly stressful, thus carers are more likely to suffer from psychological problems, such as ...
Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...
Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...
Popular weight loss medications like Ozempic can help reverse low testosterone levels in men with obesity or Type 2 diabetes, according to new research.